Ovid Therapeutics Inc.

US$2.85As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:OVIDHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (14.68%)
Div yield —
ROE (25.96%)
Biotechnology
Beta (5Y) 0.24
PE TTM —
TSR TTM 105.04%
Mkt cap US$556.6M
ROIC (72.03%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.40
19.32%
(56.96%)
Hold 11|12|2|5|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.06
0.06
0.06
34.12%
25.32%
25.25%
16.80%
Revenue$M
42.66
43.73
42.97
41.99
3.92%
3.14%
2.85%
3.12%
Peers (US$556.6M)
Cap (US$)
PE
542.4M
—
Capital
TTM
5Y
10Y
Leveragex
1.642
(0.536)
(0.439)
EBIT/Intx
1.872
0.089
0.095
Own earn%
(140.39)
23.25
3.92
Sh yield%
18.57
22.86
23.11
Owners
Insiders/Inst%
4.48
67.43
Short interest%
0.62
SBC / revenue%
5.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
18–29
$1 testx
0.4
Incr. ROIC%
8